{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T10:53:35Z","timestamp":1778151215810,"version":"3.51.4"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100012172","name":"Double First Class University Plan","doi-asserted-by":"publisher","award":["CPU2018 GY33"],"award-info":[{"award-number":["CPU2018 GY33"]}],"id":[{"id":"10.13039\/501100012172","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82074114"],"award-info":[{"award-number":["82074114"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Life Sciences"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1016\/j.lfs.2022.120882","type":"journal-article","created":{"date-parts":[[2022,8,10]],"date-time":"2022-08-10T22:43:27Z","timestamp":1660171407000},"page":"120882","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Obeticholic acid aggravates liver injury by up-regulating the liver expression of osteopontin in obstructive cholestasis"],"prefix":"10.1016","volume":"307","author":[{"given":"Jie","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zihang","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haoran","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qipeng","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yingying","family":"Miao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yunxia","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qinwei","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaofei","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ziling","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinliang","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qianhui","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luyong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhenzhou","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.lfs.2022.120882_bb0005","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1146\/annurev-pharmtox-010818-021059","article-title":"Drug therapies for chronic cholestatic liver diseases","volume":"60","author":"Wagner","year":"2020","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.lfs.2022.120882_bb0010","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1002\/hep.24229","article-title":"Drug-induced cholestasis","volume":"53","author":"Padda","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.lfs.2022.120882_bb0015","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1136\/gutjnl-2021-324305","article-title":"Novel therapeutic targets for cholestatic and fatty liver disease","volume":"71","author":"Trauner","year":"2022","journal-title":"Gut"},{"key":"10.1016\/j.lfs.2022.120882_bb0020","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.14309\/ajg.0000000000000268","article-title":"Primary biliary cholangitis and primary sclerosing cholangitis","volume":"114","author":"Yokoda","year":"2019","journal-title":"Am. J. Gastroenterol."},{"key":"10.1016\/j.lfs.2022.120882_bb0025","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1111\/liv.13306","article-title":"Management of cholestatic disease in 2017","volume":"37","author":"de Vries","year":"2017","journal-title":"Liver Int."},{"key":"10.1016\/j.lfs.2022.120882_bb0030","first-page":"15","article-title":"Agonist endowed with anticholestatic","volume":"45","author":"Pellicciari","year":"2002","journal-title":"Society"},{"key":"10.1016\/j.lfs.2022.120882_bb0035","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1002\/hep.28932","article-title":"Long-term clinical impact and cost-effectiveness of obeticholic acid for the treatment of primary biliary cholangitis","volume":"65","author":"Samur","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.lfs.2022.120882_bb0040","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1056\/NEJMoa1509840","article-title":"A placebo-controlled trial of obeticholic acid in primary biliary cholangitis","volume":"375","author":"Nevens","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.lfs.2022.120882_bb0045","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/S0140-6736(14)61933-4","article-title":"Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial","volume":"385","author":"Neuschwander-Tetri","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.lfs.2022.120882_bb0050","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1002\/hep.30150","article-title":"Ductular reaction in liver diseases: pathological mechanisms and translational significances","volume":"69","author":"Sato","year":"2019","journal-title":"Hepatology"},{"key":"10.1016\/j.lfs.2022.120882_bb0055","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1002\/hep.28274","article-title":"Integrin \u03b1v\u03b26 critically regulates hepatic progenitor cell function and promotes ductular reaction, fibrosis, and tumorigenesis","volume":"63","author":"Peng","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.lfs.2022.120882_bb0060","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1136\/gutjnl-2013-306290","article-title":"Galectin-3 regulates hepatic progenitor cell expansion during liver injury","volume":"64","author":"Hsieh","year":"2015","journal-title":"Gut"},{"key":"10.1016\/j.lfs.2022.120882_bb0065","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1152\/ajpgi.00222.2012","article-title":"Hepatic stellate cells and portal fibroblasts are the major cellular sources of collagens and lysyl oxidases in normal liver and early after injury","volume":"304","author":"Perepelyuk","year":"2013","journal-title":"Am. J. Physiol.Gastrointest. Liver Physiol."},{"key":"10.1016\/j.lfs.2022.120882_bb0070","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1136\/gutjnl-2016-313392","article-title":"The HLF\/IL-6\/STAT3 feedforward circuit drives hepatic stellate cell activation to promote liver fibrosis","volume":"67","author":"Xiang","year":"2018","journal-title":"Gut"},{"key":"10.1016\/j.lfs.2022.120882_bb0075","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1002\/hep.28622","article-title":"The secretin\/secretin receptor axis modulates liver fibrosis through changes in transforming growth factor-\u03b21 biliary secretion in mice","volume":"64","author":"Wu","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.lfs.2022.120882_bb0080","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1055\/s-0031-1272832","article-title":"Epithelial-mesenchymal interactions in biliary diseases","volume":"31","author":"S.M. Fabris","year":"2011","journal-title":"Semin. Liver Dis."},{"key":"10.1016\/j.lfs.2022.120882_bb0085","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1002\/hep.30662","article-title":"Cholangiocyte-derived exosomal long noncoding RNA H19 promotes hepatic stellate cell activation and cholestatic liver fibrosis","volume":"70","author":"Liu","year":"2019","journal-title":"Hepatology"},{"key":"10.1016\/j.lfs.2022.120882_bb0090","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1111\/j.1440-1827.2011.02649.x","article-title":"Osteopontin, intrinsic tissue regulator of intractable inflammatory diseases","volume":"61","author":"Uede","year":"2011","journal-title":"Pathol. Int."},{"key":"10.1016\/j.lfs.2022.120882_bb0095","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1136\/gutjnl-2013-306373","article-title":"Osteopontin induces ductular reaction contributing to liver fibrosis","volume":"63","author":"Wang","year":"2014","journal-title":"Gut"},{"key":"10.1016\/j.lfs.2022.120882_bb0100","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1111\/liv.14490","article-title":"A novel non-bile acid FXR agonist EDP-305 potently suppresses liver injury and fibrosis without worsening of ductular reaction","volume":"40","author":"An","year":"2020","journal-title":"Liver Int."},{"key":"10.1016\/j.lfs.2022.120882_bb0105","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1016\/j.jhep.2017.01.013","article-title":"Steroidal or non-steroidal FXR agonists \u2013 is that the question?","volume":"66","author":"Verbeke","year":"2017","journal-title":"J. Hepatol."},{"key":"10.1016\/j.lfs.2022.120882_bb0110","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1172\/JCI64551","article-title":"The TGR5 receptor mediates bile acid \u2013 induced itch and analgesia","volume":"123","author":"Alemi","year":"2013","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.lfs.2022.120882_bb0115","doi-asserted-by":"crossref","first-page":"1890","DOI":"10.1002\/hep.29569","article-title":"A randomized trial of obeticholic acid monotherapy in patients with primary biliary cholangitis","volume":"67","author":"Kowdley","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.lfs.2022.120882_bb0120","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1002\/hep.26521","article-title":"Human and experimental evidence supporting a role for osteopontin in alcoholic hepatitis","volume":"58","author":"Morales-Ibanez","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.lfs.2022.120882_bb0125","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1053\/j.gastro.2007.02.033","article-title":"Gene expression profiles during hepatic stellate cell activation in culture and in vivo","volume":"132","author":"Minicis","year":"2007","journal-title":"Gastroenterology"},{"key":"10.1016\/j.lfs.2022.120882_bb0130","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1002\/hep.23998","article-title":"Osteopontin is induced by hedgehog pathway activation and promotes fibrosis progression in nonalcoholic steatohepatitis","volume":"53","author":"Syn","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.lfs.2022.120882_bb0135","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.jhep.2005.07.024","article-title":"Osteopontin expression in normal and fibrotic liver. Altered liver healing in osteopontin-deficient mice","volume":"44","author":"Lorena","year":"2006","journal-title":"J. Hepatol."},{"key":"10.1016\/j.lfs.2022.120882_bb0140","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1136\/gutjnl-2011-301857","article-title":"NKT-associated hedgehog and osteopontin drive fibrogenesis in non-alcoholic fatty liver disease","volume":"61","author":"Syn","year":"2012","journal-title":"Gut"},{"key":"10.1016\/j.lfs.2022.120882_bb0145","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.immuni.2004.08.012","article-title":"Osteopontin as a mediator of NKT cell function in T cell-mediated liver diseases","volume":"21","author":"Diao","year":"2004","journal-title":"Immunity"},{"key":"10.1016\/j.lfs.2022.120882_bb0150","doi-asserted-by":"crossref","first-page":"8988","DOI":"10.1002\/jcp.27571","article-title":"Thrombin cleavage of osteopontin controls activation of hepatic stellate cells and is essential for liver fibrogenesis","volume":"234","author":"Cui","year":"2019","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.lfs.2022.120882_bb0155","doi-asserted-by":"crossref","first-page":"28261","DOI":"10.1074\/jbc.M103608200","article-title":"Osteopontin, a novel substrate for matrix Metalloproteinase-3 (Stromelysin-1) and matrix Metalloproteinase-7 (matrilysin)*","volume":"276","author":"Agnihotri","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.lfs.2022.120882_bb0160","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1136\/gutjnl-2013-306484","article-title":"Osteopontin neutralisation abrogates the liver progenitor cell response and fibrogenesis in mice","volume":"64","author":"Coombes","year":"2015","journal-title":"Gut"},{"key":"10.1016\/j.lfs.2022.120882_bb0165","doi-asserted-by":"crossref","first-page":"3569","DOI":"10.1002\/stem.2072","article-title":"Osteopontin promotes hepatic progenitor cell expansion and tumorigenicity via activation of \u03b2-catenin in mice","volume":"33","author":"Liu","year":"2015","journal-title":"Stem Cells"},{"key":"10.1016\/j.lfs.2022.120882_bb0170","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1111\/hepr.12166","article-title":"Osteopontin: versatile modulator of liver diseases","volume":"44","author":"Nagoshi","year":"2014","journal-title":"Hepatol. Res."}],"container-title":["Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320522005823?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320522005823?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T23:05:13Z","timestamp":1762211113000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0024320522005823"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":34,"alternative-id":["S0024320522005823"],"URL":"https:\/\/doi.org\/10.1016\/j.lfs.2022.120882","relation":{},"ISSN":["0024-3205"],"issn-type":[{"value":"0024-3205","type":"print"}],"subject":[],"published":{"date-parts":[[2022,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Obeticholic acid aggravates liver injury by up-regulating the liver expression of osteopontin in obstructive cholestasis","name":"articletitle","label":"Article Title"},{"value":"Life Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lfs.2022.120882","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"120882"}}